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EVALUATING THE EFFECT OF PREECLAMPSIA AND TIME INTERVAL ON  
 
SUBSEQUENT PREGNANCIES BLOOD PRESSURE 
 
LINDSAY HOWE 
ABSTRACT 
Introduction 
 Preeclampsia, a hypertensive disorder of pregnancy, affects 3% to 7% of 
women throughout the world. Preeclampsia is a leading cause of maternal and 
infant mortality worldwide, occurring primarily in nulliparous women. Despite 
extensive research over the past decade, the underlying pathophysiological 
mechanisms of the disease are largely unknown. A recent hypothesis has 
suggested that when a pregnancy is complicated by preeclampsia, it is the result 
of an inability of the maternal cardiovascular system to fully adapt to the 
physiologic challenge of pregnancy. This may result when there is an underlying 
and predisposing prepregnancy maternal cardiovascular state that leads to the 
pathophysiologic consequences of preeclampsia when pregnancy is 
superimposed.  
 Despite evidence for familial predisposition and presumed multifactorial 
genetic inheritance, preeclampsia generally occurs in first pregnancies and does 
not recur when the interpregnancy interval is short. One explanation for these 
observations is that pregnancy itself modifies the maternal cardiovascular system 
in ways that persist postpartum and reduce the risk for preeclampsia recurrence, 
at least for a limited period of time. It has been demonstrated that the maternal 
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cardiovascular system is remodeled during pregnancy, and these changes 
extend postpartum. The long lasting reduction in mean arterial pressure 
postpartum that pregnancy induces, and the cardiovascular remodeling that 
accounts for this, may allow for easier adaptation to volume expansion in 
subsequent pregnancies, even when the first pregnancy was complicated by 
preeclampsia. As the maternal cardiovascular system returns, over time, to the 
baseline condition, this protective effect diminishes. With this knowledge, we 
hypothesize that the length of time between pregnancies is negatively correlated 
to the likelihood of recurrence of preeclampsia, and more narrowly that the length 
of time between pregnancies is inversely associated with mean arterial pressure 
differences comparing pregnancies across all trimesters. 
 
Methods 
This study was a retrospective chart review of existing medical records. 
We reviewed medical records of women who had been diagnosed with 
preeclampsia at Fletcher Allen Health Care, during their first advanced 
pregnancy between 1995 and 2014, who went on to have a subsequent 
pregnancy within that time period. We aimed to identify factors that could affect 
the blood pressure and risk of preeclampsia in women who were previously 
diagnosed, including previous medical history and demographic variables. We 
collected blood pressures from each pregnancy, across each trimester, marking 
the recurrence of preeclampsia and other complications. Mean antepartum mean 
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arterial blood pressure, pulse pressure, and systolic and diastolic blood 
pressures were calculated and compared between pregnancies examining 
differences as a function of interpregnancy interval.  
 
Results 
 One hundred and seventy two subjects were identified for review. Overall, 
there was evidence of a significant association of interpregnancy interval (IPI) 
and the difference in mean arterial pressure (MAP) between pregnancies 
(p=0.04). The mean MAP of pregnancy decreased significantly between first and 
second pregnancies when the interpregnancy interval was <24 months 
(p=0.0018) and 24-48 months (p=0.0003), but the change was non-significant at 
interpregnancy intervals of >48 months (p=0.55). The mean MAP during the third 
trimester, specifically, decreased significantly between first and second 
pregnancies across all subject groups (IPI <24 months: p<0.0001; IPI 24-48 
months: p<0.0001; IPI >48 months: p=0.03). Preeclampsia recurred in 39 of the 
second pregnancies. The recurrence rate of preeclampsia did not vary 
significantly with interpregnancy interval (p=0.21). 
 
Discussion/Conclusions 
 The interval between preeclamptic pregnancies and subsequent 
pregnancies has an influence on the MAP of the second pregnancy. There is 
good evidence of a temporal influence, in that the shorter interpregnancy 
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intervals resulted in a greater reduction in MAP when compared to the longer 
interpregnancy interval. We believe that with additional research on 
interpregnancy intervals >48 months, there could be more a conclusive 
association identified between the rate of recurrence of preeclampsia and the 
length of interpregnancy interval. 
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INTRODUCTION 
 
Pregnancy, a physiologic “stress test of life” (Williams, 2003), requires the 
maternal body to adapt to significant demanding physiologic changes. The 
adaptive limitations of this maternal response are challenged in every pregnancy, 
and in some individuals, an inability to fully adapt to the physiologic challenge 
represented by gestation may lead to pathophysiologic consequences. We 
believe that preeclampsia, a disorder characterized by the new onset of 
hypertension and end organ injury, and a major contributor to perinatal and 
maternal mortality, is a disease that results from a limited ability of the maternal 
organism to adapt to pregnancy, specifically the physiologic volume expansion 
that is required for healthy pregnancy outcomes. Preeclampsia is defined by 
new-onset hypertension, and is often accompanied by proteinuria  (the excretion 
of 300 mg or more of protein in a 24 hour period) or evidence of other end organ 
effects (Table 1). Hypertension is defined by a systolic blood pressure of ≥140 
mm Hg, or a diastolic of ≥90 mm Hg. Severe preeclampsia, diagnosed by systolic 
blood pressure of ≥160 mm Hg or a diastolic blood pressure of ≥110 mm Hg, is 
primarily observed in first pregnancies (American College of Obstetricians and 
Gynecologists & American College of Obstetricians and Gynecologists, 2013; 
Barton & Sibai, 2008). The incidence of preeclampsia is approximately 3% to 7% 
in the general population (Basso et al., 2001). Due to lifestyle changes, and 
medical advances (i.e. increased obesity and assisted reproduction) as well as 
increased maternal ages, all of which are positively associated with disease, the 
	  2 
rates of severe preeclampsia rose 322% between 1980 and 2010 (Ananth et al., 
2013). Unfortunately, knowledge of this disease remains limited, and more 
research will be necessary to understand its etiology and thereby decrease the 
damaging impact that preeclampsia has on women, children, and families 
worldwide. 
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Table 1: Diagnostic Criteria of Preeclampsia: Diagnostic criteria as 
determined by the American College of Obstetrics and Gynecology. This figure 
was taken from Hypertension in Pregnancy guidelines by ACOG (American 
College of Obstetricians and Gynecologists & American College of Obstetricians 
and Gynecologists, 2013). 
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Physiological manifestations of preeclampsia frequently include increased 
vascular resistance and reduced plasma volume, which are associated with the 
hypertension (Hale et al., 2010). Preeclampsia can present in a variety of unique 
ways and the severity and symptoms vary between women. About one quarter of 
women diagnosed with preeclampsia develop HELLP syndrome, defined by 
hemolysis, elevated liver functions, and a low platelet count. Other preeclamptic 
women do not develop any symptoms until after parturition (Osol & Bernstein, 
n.d.). Preeclampsia can progress to eclampsia, which is defined by the new 
onset of seizures, and can lead to stroke and ultimately death for both the mother 
and fetus. Most cases of preeclampsia occur in nulliparous women (women 
without prior pregnancies beyond 20 weeks) near term, but approximately 10% of 
cases occur before 34 weeks of gestation (van Rijn et al., 2006). If the fetus 
survives the pregnancy, serious fetal complications can occur as a result of 
preeclampsia including growth restriction, preterm delivery, placental abruption 
and ultimately, significant neonatal morbidity and developmental delays (Barton 
& Sibai, 2008).  Adding to the overall uncertainty and ambiguity, the fundamental 
pathophysiologic mechanism of preeclampsia remains largely unknown 
(Bernstein et al., 1998). 
There are a number of factors thought to increase the risk of preeclampsia 
including prepregnancy hypertension (including chronic hypertension), obesity 
(associated with insulin resistance), change of partner between pregnancies, a 
long interpregnancy interval, diabetes mellitus, increased maternal age, the use 
of assisted reproduction technologies, and pregnancies resulting in multiple 
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gestation (Barton & Sibai, 2008; Lynch et al., 2002; “Preeclampsia and High 
Blood Pressure During Pregnancy - ACOG,” n.d.). Although these risk factors 
have been established, there is no proven dependable method of predicting 
preeclampsia. Current predicative tests for preeclampsia include uterine artery 
waveform analysis and uterine notching in early or mid pregnancy employing 
ultrasound imaging, but these prognostic indicators have proven to have 
relatively low predictive values (Hale et al., 2010).  
Women who receive the diagnosis of preeclampsia are often administered 
magnesium sulfate to protect them from developing seizures, as well as 
antihypertensive medication to combat the increases in blood pressure (Abad et 
al., 2015; Barton & Sibai, 2008). There is no current treatment for preeclampsia 
except this symptomatic management or delivery when the disease is deemed to 
represent an imminent maternal risk. Despite efforts to prolong pregnancy, 
worsening disease often requires preterm (>37 weeks gestation) delivery when 
disease presents prior to term gestation (“Preeclampsia and High Blood Pressure 
During Pregnancy - ACOG,” n.d.).   
 
Intolerance to Volume Expansion 
Over the past decade, extensive research has been conducted to 
investigate the numerous pathophysiologic abnormalities of preeclampsia and to 
attempt to determine potential etiologies. Women with chronic hypertension have 
a 25% incidence of preeclampsia. Woman with severe chronic hypertension have 
an incidence that approaches 50% (Barton & Sibai, 2008). Women who develop 
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preeclampsia have been found to have increased arterial stiffness, as observed 
by an increased pre-pregnancy pulse pressure and pulse wave velocity (Hale et 
al., 2010; Hausvater et al., 2012). This increased arterial stiffness could result in 
a maternal cardiovascular system that is intolerant to the volume expansion 
required by pregnancy, leading to clinical hypertension (Bernstein et al., 1998). 
This hypothesis is supported by evidence of an increased risk of preeclampsia 
with multiple gestation, which requires a greater degree of volume expansion in 
comparison to singleton pregnancies (Lynch et al., 2002). Further support is 
offered by a decrease in incidence of preeclampsia in smokers. Smoking reduces 
the degree of expansion of plasma volume, protecting the maternal 
cardiovascular system from preeclampsia (Bruinse et al., 1985). Increased 
arterial stiffness not only potentially complicates a pregnancy, but it is also a 
known risk of heart failure, stroke, and coronary heart disease later in life (Hale et 
al., 2013). These are long-term outcomes that have been linked to the 
development of preeclampsia during pregnancy (Bushnell & Chireau, 2011; 
Mannisto et al., 2013; “Preeclampsia and High Blood Pressure During Pregnancy 
- ACOG,” n.d.). It has been demonstrated that women diagnosed with severe 
preeclampsia are more likely to develop cardiovascular disease at an earlier age 
than women diagnosed with preeclampsia without severe features (Osol & 
Bernstein, n.d.) 
Even during uncomplicated first pregnancies, there is the suggestion that 
the maternal vascular system is stressed by the physiologic volume expansion. 
The majority of primigravidas, women in their first pregnancy, demonstrate an 
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increase of at least 20 mm Hg in diastolic blood pressure by the third trimester, 
while this rise in blood pressure is much less common in subsequent 
pregnancies. This suggests that even with an uncomplicated pregnancy, the 
ability to control blood pressure is challenged, and that the physiologic ability to 
manage plasma volume changes is enhanced in multiparous women 
(MacGillivray et al., 1969). 
One mechanism that limits the increase in intravascular pressure is the 
endothelial response to shear stress (Koller et al. 1993). When the endothelial 
cells are exposed to increases in shear stress, they produce vasoactive 
substances, such as nitric oxide. These substances work to increase vessel 
diameter, protecting the maternal cardiovascular system from an increase in 
blood pressure (Chambers et al., 2001; López-Jaramillo et al, 2001).  In 
preeclamptic conditions, this mechanism appears inadequate, unable to fully 
compensate for the significantly elevated intraluminal pressures, resulting in 
endothelial damage (Chambers et al., 2001).   
 
Vascular Remodeling and Recurrence 
Despite evidence for familial predisposition and presumed multifactorial 
genetic inheritance, preeclampsia generally occurs in first pregnancies and does 
not recur when interpregnancy interval is short (Ward & Lindheimer, 2009). This 
may result from pregnancy associated cardiovascular remodeling. It has been 
found that the cardiovascular remodeling that occurs during pregnancy extends 
postpartum. Due to these cardiovascular adaptations, there is a significant 
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decrease in mean arterial pressure (MAP), as well as pulse wave velocity, from 
pre-pregnancy to postpartum, in woman who experience a term pregnancy (Hale 
et al., 2013; Morris et al., 2015). Examining the relationship of blood pressure in 
uncomplicated first pregnancies compared with subsequent normal pregnancies 
within individual women, we and others observed that blood pressure was lower, 
across all trimesters in subsequent pregnancies. This reduction in MAP was 
found to diminish with time (Mikolajczyk et al., 2008; Bernstein et al. 2005). The 
interval of time between pregnancies, therefore, is negatively correlated to the 
difference in MAP between pregnancies. Additionally, Clapp and Capeless 
discovered there is increased cardiac output, as well as a decrease in peripheral 
resistance, maintained through one year postpartum when compared to 
measures obtained prior to pregnancy (Clapp & Capeless, 1997). 
It is believed that the cardiovascular remodeling that occurs during 
pregnancy and which persists postpartum might facilitate the accommodation of 
increased plasma volume, protecting the maternal cardiovascular system in 
future pregnancies. While preeclampsia occurs during approximately 3.9% of first 
pregnancies, it occurs in only approximately 1.7% of subsequent pregnancies 
(Skjaerven et al., 2002).  In general, the incidence of recurrence of the disease is 
between 5% and 25%, depending on the severity, and gestational age at onset, 
of the disease in previous pregnancies (McDonald et al., 2009; van Rijn et al., 
2006). In the cases where preeclampsia did recur, it is typically less severe and 
the pregnancies often progressed without significant maternal or fetal 
complication (McDonald et al., 2009). 
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The risk of recurrence is directly correlated to the interval between 
pregnancies. The odds ratio for preeclampsia recurrence was found to be 1.16 
per additional year between pregnancies. If the inter-birth interval was 10 years 
or longer, the risk of preeclampsia is approximately that of nulliparous women 
(Skjaerven et al., 2002). This increase in risk with time is related to MAP. Wright 
et al. demonstrated that MAP increases significantly with inter-pregnancy interval 
(Wright et al., 2015). This evidence suggests that the protective effect of 
preceding pregnancies against preeclampsia is only transient, and that MAP and 
the maternal cardiovascular system returns to baseline after a certain interval of 
time (Skjaerven et al., 2002).  
While we have demonstrated that second pregnancies are associated with 
reduced blood pressure when compared to uncomplicated first pregnancies as a 
function of the time between conceptions, we have not examined the same 
phenomenon and, if present, its associated time frame, when those first 
pregnancies are complicated by preeclampsia. While there are numerous 
theories about preeclampsia and its fundamental mechanisms, little attention has 
been paid to the mechanism underlying its lack of uniform recurrence in 
subsequent pregnancies. By studying women who have been previously 
diagnosed with preeclampsia and following them throughout subsequent 
pregnancies, we hope to shed light on the fundamental pathophysiology of 
preeclampsia.  
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The Present Study 
 It has been shown that the maternal cardiovascular system is remodeled 
during pregnancy, and these changes extend postpartum. The persistent 
decrease in mean arterial pressure postpartum may identify a cardiovascular 
system that allows for easier adaptation to volume expansion in subsequent 
pregnancies, even if the first pregnancy was complicated by preeclampsia (i.e. 
increased vascular compliance). However as the maternal cardiovascular system 
returns to the baseline condition over time, this protective effect diminishes. With 
this knowledge, we hypothesize that the length of time between pregnancies is 
negatively correlated to the likelihood of recurrence of preeclampsia, and more 
narrowly that the length of time between pregnancies is inversely associated with 
mean arterial pressure differences comparing pregnancies across all trimesters. 
 
Specific Aims 
In order to evaluate the effect of time interval on changes in MAP and 
recurrence rate of preeclampsia, we will: 
(1) Examine the association of the time interval between pregnancies and 
the change in mean arterial pressure, systolic blood pressure, diastolic blood 
pressure, and pulse pressure (an index of vascular stiffness) across all three 
trimesters of pregnancy.  
(2) Examine the association of the time interval between pregnancies and 
the likelihood of recurrence of preeclampsia in subsequent pregnancies. 
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We expect that this study will show: 
(1) The time interval between pregnancies will be inversely associated 
with the changes in MAP, systolic blood pressure, diastolic blood pressure, and 
pulse pressure in subsequent pregnancies in women who were previously 
diagnosed with preeclampsia 
(2) The time interval between pregnancies will be inversely associated 
with the recurrence rate of preeclampsia. 
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METHODS 
 
Identification of Research Subjects 
This study was a retrospective chart review using existing medical 
records. All research was approved by the University of Vermont Institutional 
Review Board, Committee on Human Research in Medical Sciences. In order to 
retrieve relevant medical records, we used OBNet, a registry used by Fletcher 
Allen Health Care (FAHC) to collect information concerning births at FAHC and 
at hospitals in the surrounding regions. We reviewed medical records of the 
women who had been diagnosed with preeclampsia at FAHC during their first 
pregnancy between 1995 and 2014.  We restricted our research to women who 
were nulliparous before the pregnancy during which they were diagnosed. In 
addition, we only investigated subjects who had a second delivery at FAHC. It 
was required that all subjects had blood pressure readings across at least two 
trimesters of each pregnancy. Trimesters were defined as first (weeks 1-12+6 of 
gestation), second (weeks 13-25+6 of gestation), and third (weeks >26 of 
pregnancy) (Bernstein et al., 2005). Woman who had been previously diagnosed 
with thrombophilic disease, where fetal anomalies were identified or who had a 
pregnancy that resulted in multiple gestations, were excluded from this study.  
In addition, there were two subjects that had been previously recruited for 
a separate clinical study conducted by at FAHC. Although they delivered their 
first born at an outside institution, where they were diagnosed with preeclampsia, 
their second deliveries were at FAHC. They matched all the inclusion criteria for 
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this study, so their pregnancy data was appropriate for inclusion in this study. If 
external medical records were needed for review, the outside institutions were 
contacted and permission to collect data from their medical records was 
requested.  
 
Data Collection 
  Once the subjects were determined using the identifiers, we began to 
collect data from their medical records. We aimed to identify factors that could 
affect the blood pressure and risk of preeclampsia in woman who were 
previously diagnosed. 
These factors included age, race, educational level, smoking status, pre-
pregnancy weight and body mass index (BMI), total weight gained during the 
pregnancy, number of prenatal visits, medications used during pregnancy, and 
whether there were any spontaneous or therapeutic abortions between the two 
pregnancies of interest. If the subject had a history of chronic hypertension, 
antihypertensive medication, or if the patient was a Maternal-Fetal Medicine 
patient, this was documented. The gravidity, parity, and number of abortions 
(including spontaneous, therapeutic, or elective) of each subject were also noted. 
In addition, the newborn’s birth weight, gestational age, birth date and time, and 
Appearance, Pulse, Grimace, Activity, and Respiratory (APGAR) scores at one 
minute and five minutes postpartum were recorded (Appendix).  For each 
pregnancy, a maximum of 25 antepartum blood pressure readings were collected 
for each subject. Blood pressures were also recorded up to three days 
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postpartum. If more than one blood pressure reading was taken per day, a mean 
systolic and mean diastolic blood pressure value was calculated. Each subject 
was noted as diagnosed with preeclampsia without severe features (PEC), or 
preeclampsia with severe features (PEC (severe)). It was also reported if the 
subject was diagnosed with HELLP in addition to severe preeclampsia. In the 
case of second pregnancies, diagnoses of gestational hypertension or no 
diagnosis were possibilities. All data was kept in a data sheet that was only 
accessible to the research team. 
 The study subjects were segregated into three groups depending on their 
interpregnancy interval. The interpregnancy interval (IPI) were divided as follows: 
<24 months (IPI <24), 24-48 months (IPI 24-48), and >48 months (IPI >48).  
  
Statistical Analysis 
  The clinical and demographic characteristics of the first and subsequent 
pregnancies were compared using paired t-tests and McNemar’s tests for 
continuous and categorical measures, respectively. Differences in mean arterial 
pressure, systolic pressure, diastolic pressure, and pulse pressure between the 
first and subsequent pregnancies were analyzed using repeated measures 
analyses of variance. The model included two within-subject factors, pregnancy 
(initial/subsequent), trimester (1st, 2nd, 3rd), and one across-subject factor 
interpregnancy interval (<24 months, 24-48 months, > 48 months), and their 
interactions. Other comparisons of continuous and categorical outcomes across 
the three groups defined by length of interpregnancy interval were done using 
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one way analyses of variance and chi square tests, respectively. All statistical 
analyses were performed using SAS Statistical Software Version 9.3 (SAS 
Institute, Cary NC).  Statistical significance was determine based on p<.05.  
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RESULTS 
 
Clinical and Demographic Characteristics  
 First and second pregnancies of 172 subjects were included in the 
analyses. When grouped according to interpregnancy intervals, 40 subjects had 
interpregnancy intervals of <24 months, 105 subjects had interpregnancy 
intervals of 24-48 months, and 26 subjects had interpregnancy intervals of >48 
months. The majority of subjects were Caucasian, 97% (166/172), which is 
representative of the Vermont population. All subjects had appropriate pregnancy 
dating (consisting of an ultrasound before 20 weeks gestation). Five of the first 
pregnancies resulted in a fetal demise, while two of the second pregnancies had 
the same outcome. There were 33 subjects who had at least one abortion (either 
spontaneous or therapeutic) between the two pregnancies of interest.  
Clinical and demographic characteristics of the pregnancies are outlined in Table 
2. Table 3 depicts the differences in various clinical characteristics between the 
two pregnancies and the significance of these differences.  
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 Characteristic Pregnancy 1 Pregnancy 2 P 
Age (years) 27.9 ± 5.7 30.7 ± 5.6 p<.001 
Prepregnancy 
Weight (lbs.) 
168.2 ± 48.8 174.8 ± 53.6 p<.001 
Weight Gain (lbs.) 36.3 ± 16.7 31.3 ± 16.0 p<.001 
Gestational Age 
(weeks) 
36.4 ± 3.5 38.1 ± 2.1 p<.001 
APGAR at 1 minute 6.9 ± 2.0 7.7 ± 1.7 p<.001 
APGAR at 5 
minutes 
8.3 ± 1.6 8.8 ± 1.1 p=0.003 
Birth Weight (g) 2823 ± 959 3276 ± 72 p<.001 
Table 2: Clinical and Demographic Characteristics of Pregnancies: All data 
is expressed as mean ± standard deviation. Significance is based on paired t-
tests. 
 
Characteristic Pregnancy 1 (%) Pregnancy 2 (%) P 
Tobacco Use 14.0 10.5 p = 0.083 
CHTN 16.9 22.7 p = 0.002 
MFM Patient 17.4 26.2 p = 0.004 
Preterm Delivery 30.2 15.1 p < 0.001 
BW < 1500 grams 11.6 2.3 p < 0.001 
BW < 2500 grams 11.5 2.5 p = 0.005 
PEC 60.5 14.0 p < 0.001 
PEC (severe) 39.5 8.7 p < 0.001 
PEC (any) 100.0 22.7 p < 0.001 
HELLP 15.1 2.3 p < 0.001 
Table 3: Differences in Clinical Characteristics in the Pregnancies: For first 
and second pregnancies, percentage of subjects in each category is shown. The 
p values for the differences between the two pregnancies are stated for each 
category. Significance is based on McNemar’s test. The “PEC (any)” category 
consists of all subjects who were diagnosed with preeclampsia, regardless of 
severity of features. CHTN = Chronic hypertension; BW= birth weight; MFM = 
Maternal Fetal Medicine.  
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 When the subjects were compared with regard to their interpregnancy 
interval, the subjects who experienced interpregnancy intervals >48 months were 
significantly younger than subjects who experienced interpregnancy intervals of 
<24 months and 24-48 months (p=0.02; p=0.04). The mean age at the second 
pregnancy was not significantly different across the groups.  
 Tobacco use, chronic hypertension, use of medication (including 
antihypertensive medication), and prepregnancy weight were not significantly 
different across the subjects with different interpregnancy intervals.  
 
Mean Arterial Pressure and Interpregnancy Interval 
 Overall, there was evidence of a significant association of inter-pregnancy 
interval and the difference in MAP between pregnancies (ANOVA, P=0.04). The 
change in MAP between the first and second pregnancies was also calculated for 
each group of subjects. When pregnancy was considered as a whole, rather than 
as individual trimesters, there was a significant decrease in the MAP between 
first and second pregnancy when the interpregnancy interval was <24 months 
(p=0.0018). The same was true when the interpregnancy interval was 24-48 
months (p=0.0003). When the interpregnancy interval was >48 months, the 
overall change in MAP from first to second pregnancy was non-significant.  
In addition to the overall change in MAP between first and second 
pregnancies, the change in MAP across each trimester of the pregnancies was 
compared among the groups (Figure 1). There was a significant decrease in 
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MAP during the third trimester between first and second pregnancies in all three 
of the subject groups examined.  
 
 
 
Figure 1: Interpregnancy Interval vs. Change in MAP: For each trimester, the 
changes in MAP between first and second pregnancies are displayed for each 
group. “***” represents p<0.001, “**” represents p<0.01, and “*” represents 
p<0.05. Significance is based on analyses of variance.   
 
When the changes in mean MAP across the pregnancies were compared, 
the degrees of change in subjects with interpregnancy intervals of <24 months 
and 24-48 months were significantly greater than those subjects with an 
interpregnancy interval >48 months (p = 0.01; p=0.03). This significance is 
manifested in the change across the first trimester (p=0.02; p=0.005). This data 
is depicted in Figure 2. 
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Upon examining postpartum blood pressures, we observed a significant 
reduction in MAP on postpartum day 1 (PPD1) in the second pregnancy in all 
three of the subject groups (IPI <24 months: p= 0.001; IPI 24-48 months: 
p<0.0001; IPI >48 months: p=0.004). The differences in MAP on (PPD1) between 
first and second pregnancies were not significantly correlated with 
interpregnancy interval (p=0.95).  
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Figure 2: MAP and Interpregnancy Interval: (Top) Trends in first pregnancy 
MAP for each group of subjects, segregated by interpregnancy interval. There 
was no significant difference in the MAP of any trimester between the three 
groups. (Bottom) Trends in second pregnancy MAP for each group of subjects, 
segregated by interpregnancy interval. 
 
Systolic and Diastolic Blood Pressure and Interpregnancy Interval 
 When the three subject groups were compared, for an interpregnancy 
interval of <24 months, as well as for an interpregnancy interval of 24-48 months, 
the mean systolic blood pressure was significantly reduced between first and 
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second pregnancies (p=0.003; p=0.0001). Specifically, this significance is 
manifested in the third trimester for both subject groups (p<0.0001; p<0.0001). 
This significance does not carry over to subjects with an interpregnancy interval 
of >48 months. 
 The changes in diastolic blood pressure were also examined across the 
subject groups. When pregnancies were considered as a whole, rather than as 
individual trimesters, the mean diastolic blood pressure was significantly reduced 
in the second pregnancies compared to the first pregnancies when the 
interpregnancy intervals were <24 months and 24-48 months (p=0.006; p=0.004). 
This significance is due to the change in diastolic blood pressure during the 
second and third trimester when the interpregnancy intervals are <24 months 
(p=0.03; p=0.0003), and the third trimester only when the interpregnancy interval 
is 24-48 months (p<0.0001). When the interpregnancy interval is >48 months, the 
diastolic blood pressure is significantly higher in the first trimester, but 
significantly lower in the third trimester of the second pregnancies compared to 
the first pregnancies (p=0.001; p=0.03).  
 
Pulse Pressure and Interpregnancy Interval 
When all subjects groups were combined, the mean pulse pressures in 
the first and third trimesters were significantly lower in second pregnancies when 
compared to the first pregnancies (p=0.03; p=0.03). When third trimesters of the 
pregnancies were compared, the pulse pressure was significantly lower in the 
second pregnancy in subjects with an interpregnancy interval of <24 months, as 
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well as in subjects with an interpregnancy interval of 24-48 months (p=0.02; 
p=0.3). This significance did not carry over to subjects with an interpregnancy 
interval of >48 months.  
Although the differences in mean antepartum pulse pressures between 
first and second pregnancies were not significantly different when the subject 
groups were compared, the difference in mean pulse pressure on the first day 
postpartum (PPD1) between pregnancies was associated with the length of time 
between pregnancies (p=0.002). When the interpregnancy interval was between 
24-48 months, the mean pulse pressure on PPD1 was significantly lower in the 
second pregnancies when compared to that of the first pregnancies (p=0.02). 
When the interpregnancy interval is >48 months, the pulse pressure at PPD1 is 
significantly higher in the second pregnancies than the first pregnancies (p=0.01).  
 
Preeclampsia Recurrence 
It was required that all subjects be diagnosed with preeclampsia in their 
first pregnancy. In the second pregnancies, 38% (65/172) of the subjects 
experienced a hypertensive disorder, either preeclampsia or gestational 
hypertension. There were 39 subjects (23%) who experienced recurring 
preeclampsia in their second pregnancy (Table 4). Figure 3 depicts the first 
pregnancy diagnoses with the rate and severity of second pregnancy outcomes.  
 
	  24 
Pregnancy GH PEC PEC (severe) HELLP 
1 -  104 68 26 
2 26 24 15 4 
Table 4: Diagnoses in First and Second Pregnancies: Number of subjects 
diagnosed with gestational hypertension (GH), preeclampsia (PEC), severe 
preeclampsia, and HELLP in first and second pregnancies. Subjects with HELLP 
syndrome are also classified as having PEC (severe). 
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Figure 3: Initial Diagnosis and Second Pregnancy Outcomes: 
First pregnancy diagnoses (in bolded boxes; top to bottom: preeclampsia without 
severe features, severe preeclampsia, and HELLP) along with the outcomes of 
the subsequent pregnancies. A diagnosis of gestational hypertension (GH) was 
possible during the second pregnancy. The number of subjects (n) and 
percentage of subjects were reported for each second pregnancy outcome.  
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 It was observed that, although non-significant, there was a higher 
frequency of preeclampsia recurrence in the second pregnancies with longer 
interpregnancy interval. When the interpregnancy interval was <24 months, 
12.5% of subjects were diagnosed with preeclampsia (either with or without 
severe symptoms) in the second pregnancy, while 25.7% and 26.9% of subjects 
experienced recurrence when the interpregnancy interval was 24-48 months and 
>48 months, respectively (p=0.21). The recurrence of severe preeclampsia, 
specifically, followed the same pattern in relation to interpregnancy interval 
(p=0.6).  
 Examining all hypertensive disorders complicating second pregnancies 
there were 15 of the 40 subjects (38%) with interpregnancy intervals of <24 
months that experienced a recurrence of a hypertensive disorder (either 
preeclampsia or gestational hypertension). A hypertensive disorder occurred in 
the second pregnancies of 41 subjects (39%) and 9 subjects (35%) who 
experienced interpregnancy intervals of 24-48 months and >48 months, 
respectively.  
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DISCUSSION 
 
Basic Characteristics and Interpregnancy Interval 
 Basic demographic and clinical characteristics can affect the risk of 
developing preeclampsia. For example, increased maternal age, obesity, and 
preexisting hypertension increases the risk of preeclampsia (Barton & Sibai, 
2008; Bruinse et al., 1985). Tobacco use during pregnancy, on the other hand, 
has the opposite effect (Ananth et al., 2013). In the present study, differences in 
these basic characteristics were analyzed both across the two pregnancies and 
across the three subject groups. When the first and subsequent pregnancies 
were compared, the percent of tobacco use among the study population did not 
change significantly. As a result, tobacco use could not account for the decrease 
in mean arterial pressure observed in second pregnancies. There were, however, 
significantly more subjects with preexisting chronic hypertension, as well as more 
subjects that were patients of Maternal-Fetal Medicine during the second 
pregnancy. It can be theorized that a number of subjects were diagnosed with 
chronic hypertension following their first pregnancy, due to the persistent 
elevated blood pressures experienced during their postpartum period. It was 
expected that there would be more Maternal-Fetal Medicine patients during the 
second pregnancies. Although the rate of recurrence of preeclampsia is lower in 
multiparous women than nulliparous women, women who have had 
preeclampsia in the past are often monitored closely in their subsequent 
pregnancies to detect and manage complications. In the second pregnancies, 
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there were also significantly less preterm births and newborns with what we 
categorized as low birth weight (below 1500 grams) and very low birth weight 
(below 2500 grams). This was expected, since preeclampsia often results in both 
fetal growth restriction as well as iatrogenic preterm delivery soon after onset of 
the disease (Barton & Sibai, 2008; “Preeclampsia and High Blood Pressure 
During Pregnancy - ACOG,” n.d.). 
  When the three subject groups were compared, tobacco use, maternal 
prepregnancy weight, and rate of chronic hypertension across the three 
interpregnancy intervals were not significantly different. This suggests that any 
differences that were observed in the cardiovascular function of the women, as 
well as any differences in the rate of recurrence of preeclampsia, across the 
subject groups were not a result of these variables. 
 The mean maternal age at the time of first pregnancy was significantly 
younger in subjects with pregnancies >48 months apart when compared to the 
shorter interpregnancy intervals. Not surprisingly, this significance disappeared at 
the time of the second pregnancies. Due to the fact that the age at the time of 
second pregnancy was approximately the same across subject groups, any 
differences that were observed during the second pregnancies across the subject 
groups could not be a result of the maternal age. Our data indicates that the 
women who experienced an interpregnancy interval of >48 months did not have 
significantly more cases of severe preeclampsia or HELLP in their first 
pregnancy. If that were the case, these women might have been more cautious 
about conceiving a second time, causing them to wait longer in between 
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pregnancies. It can be theorized, however, that the younger women did not feel 
the need to conceive soon after their first pregnancy, even if they desired to 
become pregnant in the future. It is widely known that with advanced maternal 
age, the risk of adverse outcomes, such as chromosomal abnormalities, preterm 
birth, and preeclampsia in pregnancy increase and reductions in fertility are 
observed (Ananth et al., 2013; Bayrampour et al., 2012). The older women, those 
who experienced interpregnancy intervals of <24 months and 24-48 months, 
having already experienced a complicated pregnancy, may have been more 
inclined to conceive soon after their first pregnancy in order to avoid the risks 
associated with advanced maternal age. Regardless of the confounding reason, 
the age at the time of second pregnancy was approximately the same across the 
different interpregnancy intervals. Maternal age, therefore, could not account for 
differences seen between the subject groups.   
 
Mean Arterial Pressure and Interpregnancy Interval 
The maternal cardiovascular system is challenged during pregnancy, 
largely due to a significant increase in plasma volume. This can result in an 
increase in blood pressure across all three trimesters of pregnancy, even in 
uncomplicated pregnancies (Bernstein et al., 2005). It has been found that 
women who undergo normal, uncomplicated pregnancies routinely have lower 
MAP throughout the second pregnancy when compared to the first and that this 
reduction in MAP is a function of the interval between pregnancies (Bernstein et 
al., 2005; Mikolajczyk et al., 2008). In this study, we examined whether this trend 
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held true when the first pregnancy was complicated by preeclampsia. In addition 
to MAP, we examined the changes in systolic blood pressure, diastolic blood 
pressure, and pulse pressure across the pregnancies. The change in MAP 
across the third trimesters of all three subject groups was significant. This was 
expected due to the fact that there was a selection bias for high blood pressure in 
the first pregnancies, and the majority of cases of preeclampsia are diagnosed 
during the third trimester of pregnancy (van Rijn et al., 2006). Interestingly, we 
observed a significant increase in MAP overall when comparing MAP across 
pregnancy as a function of interpregnancy interval. These differences were 
specifically identified within the first trimester between first and second 
pregnancies in subjects with an interpregnancy interval of >48 months. Of note in 
this study, this range (>48 months) of interpregnancy interval was 
underrepresented in relation to the shorter interpregnancy intervals and we may 
have been underpowered to identify differences and trends in blood pressure 
across all trimesters that were specific to this interpregnancy interval. Further 
research would be useful to clarify the relationship of longer interpregnancy 
intervals with difference in blood pressure before a conclusion for the specific 
association is made.  
When each pregnancy was considered as a whole, rather than individual 
trimesters, and compared directly to each other, the reduction in MAP between 
the two pregnancies was only significant with interpregnancy intervals of <24 
months and 24-48 months. When the interpregnancy interval was >48 months, 
the change in MAP between the two pregnancies was not significant. This 
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evidence suggests that even when the first pregnancy is preeclamptic, there is a 
protective effect on the maternal cardiovascular system that extends postpartum. 
Additionally, when the degree of changes in MAP were compared among the 
subject groups, the differences between the subject groups were significant. 
Specifically, subjects with interpregnancy interval of <24 months and 24-48 
months had a significantly greater reduction in MAP across pregnancies than 
subjects who experienced an interpregnancy interval of >48 months. Due to the 
fact that the mean MAP of the first pregnancies were not significantly different 
when the groups were compared, these differences in the degree of change in 
MAP must be due to the MAP in the second pregnancies. 
It has been demonstrated that following a healthy pregnancy, the 
reduction in MAP diminishes as the interval between pregnancies increases. 
Bernstein et al. found that the changes in third trimester blood pressures 
between first and second pregnancies approached zero when the interpregnancy 
interval reached four to five years (Bernstein et al., 2005). Another study, using a 
large cohort of women suggested that the MAP returned to the nulliparous 
baseline after only two to three years (Mikolajczyk et al., 2008). Unlike the 
present study, both of these studies looked at women who had experienced an 
uncomplicated, non-preeclamptic first pregnancy. When we observed woman 
who were diagnosed with preeclampsia during their first pregnancy, the mean 
MAP of the second pregnancy did not approach nulliparous levels even at the 
longest interpregnancy interval. However, as the time interval between 
pregnancies grew longer, the MAP across all trimesters of the second 
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pregnancies were observed to increase consistently. It was also evident that the 
trends in blood pressure changed when first and second pregnancies were 
compared. As shown in Figure 2, in the first pregnancies, which were 
complicated by preeclampsia, the mean arterial pressures of the second 
trimester were approximately equal to those of the first trimester, demonstrating 
no evidence of the second trimester reductions found in normal pregnancies. In 
the third trimester, MAP was noted to spike consistent with the onset of clinical 
preeclampsia. The second pregnancies show a trend that is much more similar to 
the blood pressures of a healthy pregnancy. In normal pregnancies, the blood 
pressure tends to decrease between first and second trimesters, and increase 
between second and third trimesters (Hermida et al., 2000). The second 
pregnancies closely mimicked this trend, suggesting that the second pregnancies 
are much more representative of normal pregnancies than they are preeclamptic 
pregnancies.  
Mikolajczyk et al. argued that because the MAP returns to baseline so 
rapidly following the first, uncomplicated pregnancy, a reduction in MAP, and its 
implications regarding vascular remodeling can not underlie the lack of uniform 
recurrence of preeclampsia in second pregnancies as the time frames do not 
match. After studying our results, we suggest, rather, that women who were 
diagnosed with preeclampsia in their first pregnancy do not follow the same 
physiological timeline as women who had a healthy first pregnancy. It has been 
demonstrated that the risk of preeclampsia in second pregnancies approximately 
equals that of nulliparous women when the interpregnancy interval is ten years or 
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greater (Skjaerven et al., 2002). Unfortunately, we did not have any subjects in 
the current study that had interpregnancy intervals nearing 10 years. Further 
research must be done in order to conclude if the increased risk of preeclampsia 
ten years postpartum is associated with mean arterial pressures that approach 
baseline, nulliparous values.   
 
Blood Pressure and Interpregnancy Interval 
 Both systolic and diastolic blood pressure followed a very similar pattern to 
MAP over the course of the two pregnancies. When each pregnancy was viewed 
as a whole, rather than as individual trimesters, both systolic and diastolic blood 
pressures were significantly reduced with interpregnancy intervals of <24 months 
and 24-48 months. When trimesters were compared, the systolic and diastolic 
blood pressures were significantly reduced only in the third trimesters of both 
subject groups. Since both systolic and diastolic blood pressures follow a similar 
pattern to mean arterial pressure across the pregnancies, this suggests that both 
values are contributing to the change in MAP across the two pregnancies. It has 
been observed that women diagnosed with preeclampsia had both elevated 
systolic and diastolic pressure when compared to women who experienced 
normal pregnancies (Hladunewich et al., 2011). Our data suggests that in the 
second pregnancies, both systolic and diastolic blood pressures are influencing 
the observed decrease in MAP. 
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Pulse Pressure and Interpregnancy Interval 
 Pulse pressure can be used as a measure of blood vessel elasticity, or 
arterial compliance. An increase in pulse pressure reflects a decrease in arterial 
compliance, and it has been observed that a higher pulse pressure is associated 
with an increased risk of preeclampsia (Dart & Kingwell, 2001; Hale et al., 2010). 
With this knowledge, it is no surprise that consistent with systolic and diastolic 
blood pressures, pulse pressure follow a similar pattern to MAP in the second 
pregnancies. The decrease in pulse pressure in the second pregnancies 
supports the finding that in preeclamptic pregnancies, there is increased pulse 
pressure suggestive of decreased arterial compliance.  
Our data showed that the changes in third trimester pulse pressure across 
pregnancies were only significant with interpregnancy intervals of <24 months 
and 24-48 months. This suggests that at the longer interpregnancy interval, the 
increase in arterial compliance, which can serve as a protective function, begins 
to diminish, or that our ability to identify real differences was diminished by the 
reduced number of pregnancies with prolonged interpregnancy interval. As the 
arterial compliance decreases with longer interpregnancy interval, we believe 
that this allows for an increased risk of preeclampsia recurrence. In the current 
study, there was a trend towards more cases of preeclampsia in the second 
pregnancies as the interpregnancy interval grew longer, which is what would be 
expected after analyzing the pulse pressure results.  
 It is noteworthy that when the changes in pulse pressure between the two 
pregnancies on the first day postpartum were compared, there appeared to be an 
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association between change in pulse pressure and length of interpregnancy 
interval as well. When the interpregnancy interval was between 28-48 months, 
the pulse pressure on the first day postpartum of the second pregnancies was 
significantly lower than that of the first pregnancies. The opposite trend was seen 
when the interpregnancy interval exceeded 48 months. This further supports the 
argument that the decrease in arterial compliance begins to diminish at greater 
interpregnancy intervals and that this may manifest in the early postpartum 
window as well.  
  
Preeclampsia Recurrence and Interpregnancy Interval 
Preeclampsia is often referred to as “a disease of the first pregnancy” 
(Castiglioni et al., 2014). Although there have been a multitude of theories, it is 
largely unknown as to why the disease does not occur at the same rate in 
nulliparous and multiparous women. We hypothesized that the low recurrence 
rate of preeclampsia was due to the cardiovascular modifications that occur 
during first pregnancies, protecting the maternal system from dangerously high 
blood pressures in subsequent pregnancies. In this study, the recurrence rate of 
preeclampsia was 23%, which was in agreement with recurrence rate found in 
existing literature (McDonald et al., 2009; van Rijn et al., 2006). When 
hypertension did recur in second pregnancies, it was often less severe. For 
instance, a number of the subjects were diagnosed with gestational hypertension 
during their second pregnancy. Gestational hypertension is defined by high blood 
pressure occurring during pregnancy, without the other features of preeclampsia, 
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such as proteinuria (“Preeclampsia and High Blood Pressure During Pregnancy - 
ACOG,” n.d.). When recurrence was compared among subjects who exhibited 
severe features of preeclampsia in the first pregnancy with those who did not 
exhibit such symptoms, the percentage of normal, uncomplicated second 
pregnancies was approximately equal. This suggests that the overall risk of 
recurrence of preeclampsia remains approximately the same, regardless of the 
severity of the preeclampsia during the first pregnancy in this cohort and in 
contrast to other studies (McDonald et al., 2009; van Rijn et al., 2006). However, 
a greater percentage of subjects developed severe preeclampsia in the second 
pregnancy when they were diagnosed with severe preeclampsia during the first 
pregnancy, compared to subjects who did not develop the severe features of the 
disease during their first pregnancy. This suggests that although the risk of 
developing preeclampsia is approximately equal regardless of severity of disease 
during the first pregnancy, those subjects who did experience a recurrence were 
more likely to exhibit severe features in the second pregnancy if they had 
exhibited these symptoms in their first pregnancy. 
Although we found no significant difference in the rate of recurrence as the 
interpregnancy interval increased from <24 months to >48 months, there was a 
consistent increasing trend of recurrence in preeclampsia with a longer 
interpregnancy interval. The recurrence of severe preeclampsia, specifically, 
followed the same pattern in relation to interpregnancy interval. Epidemiological 
data suggests that the risk of preeclampsia returns near the nulliparous baseline 
at interpregnancy intervals of ten years or greater (Skjaerven et al., 2002). 
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Further research must be conducted on the recurrence rate of subjects with 
interpregnancy intervals within this range. We hypothesize that the inclusion of 
longer interpregnancy intervals would result in clearer associations to blood 
pressure changes and preeclampsia recurrence.  
 
Conclusions 
 In conclusion, our data suggests that the interval between 
pregnancies does have an influence on the changes in mean arterial pressure, 
systolic blood pressure, diastolic blood pressure, and pulse pressure in 
subsequent pregnancies in women who were previously diagnosed with 
preeclampsia in their first pregnancies. With longer interpregnancy intervals, 
there was a smaller degree of change in these cardiovascular variables between 
the first, preeclamptic pregnancies, and the subsequent pregnancies. Although 
the association between interpregnancy interval was not significantly associated 
with the recurrence of preeclampsia, we hypothesize that there would be a more 
conclusive result if additional data was collected on subjects with interpregnancy 
intervals approaching ten years or greater. Hopefully, with the knowledge gained 
from this study, we will be able to focus our research goals and continue to gain 
insight into the pathophysiologic mechanisms of preeclampsia.    
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APPENDIX 
 
Demographic Info: 
Study I.D: _______ MRN: ____________ Year of Birth _________     
Race: ____ Height: __ (in)  Prepregnancy Weight: ____ Highest Level Ed: _____  
Tobacco: Y / N 
Pregnancy Info: 
Gravity: 1 2 3 4 5 6 7 8 Parity: 1 2 3 4 5 6 7 8  #SAB’s: 1 2 3 4 5 6 7 8 
Previous Delivery @ FAHC? Y/ N  Date of last delivery:__/__/__  
Total # ANV: ___ 
Number of Living Children: ______ 
Pregnancy Dating (U/S before 20 weeks)? Y / N     Total Weight Gained (lbs):___ 
PMHx of any of the following (if yes; explain:) 
Condition NO YES      Details of Condition 
Chronic Hypertension    
Antihypertensive Meds    
Thrombophilic Disease    
Multiple Gestation    
MFM patient    
 
Antenatal Blood Pressure Recordings: 
EGA 
(weeks) 
BP 
(systolic) 
BP 
(diastolic) 
EGA 
(weeks) 
BP 
(systolic) 
BP 
(diastolic) 
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Intrapartum/ Postpartum:  
GH:   Y / N    Date/time of delivery: __/___/___ @ ___ 
PEC:   Y / N   EGA @ delivery: ___ ___ + ___ 
PEC (severe):  Y / N   Birth Weight (grams): _______  
HELLP:  Y / N   Apgar 1/5: ___ / ___   
Postpartum BP @ approx. 24 hours (with time): _____ @ ______ 
Med use in pregnancy?  Y/ N 
If yes, list: 1.     
  2. 
  3. 
  4. 
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BMJ BMJ: British Medical Journal  
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